Clinical Trial

Impact of CRRT on Serum Carnitine and Micronutrient Levels

Completed
View on ClinicalTrials.gov →
Summary
This study aims to investigate the changes in blood levels of micronutrients and carnitine in critically ill patients with Acute Kidney Injury (AKI) who are undergoing Continuous Renal Replacement Therapy (CRRT). While CRRT is a life-saving intervention for managing metabolic disturbances and fluid overload in patients with Stage 2-3 AKI, it may also lead to the inadvertent removal of essential micronutrients (vitamins, trace elements, and amino acids) through the extracorporeal circuit. The research will prospectively compare 100 adult patients across two groups: those receiving CRRT and those managed without CRRT. Researchers will analyze blood samples and effluent fluid to determine the clearance rates and total losses of various substances, including carnitine, selenium, zinc, and various amino acids. By comparing levels at the first hour and 24th hour of intensive care admission, the study seeks to determine if CRRT significantly contributes to micronutrient deficiencies in this vulnerable population.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-08.
Trial Details
NCT Number NCT07467889
Lead Sponsor Gulhane Training and Research Hospital
Conditions Acute Kidney Injury (Nontraumatic), Critical Illness
Enrollment 43 participants
Start Date 2023-01-01
Primary Completion 2025-03-15 (estimated)
Study Completion 2025-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-16